Tonix Pharmaceuticals
Berkeley Heights, NJ, United StatesIndustry
Tonix Pharmaceuticals was awarded up to $34 million by the US Department of Defense for a broad-spectrum antiviral programme, TNX-4200.
What it does
Threats covered
Categories
Profile
Tonix Pharmaceuticals is a Berkeley Heights, New Jersey company listed on Nasdaq under TNXP. It is developing TNX-801, a preclinical single-dose live attenuated horsepox virus vaccine intended to prevent mpox and smallpox.
More profile
It remains pre-IND, and the company expects a phase 1 study in mid-2027 pending FDA clearance. In 2025 it received a 50,000 dollar grant for TNX-801 commercialisation planning.
A separate Department of Defense Defense Threat Reduction Agency contract of up to 34 million dollars over five years supports TNX-4200, a broad-spectrum antiviral, and not TNX-801. Its quarterly reports for 2026 are public.
Most of Tonix's business is in central nervous system and other indications.
Ownership
Publicly listed on Nasdaq (TNXP)
Parent: none (publicly listed) (checked)
Sources (5)
- https://ir.tonixpharma.com/news-events/press-releases/detail/1640/tonix-pharmaceuticals-reports-second-quarter-2026-financial
- https://ir.tonixpharma.com/news-events/press-releases/detail/1626/tonix-pharmaceuticals-reports-first-quarter-2026-financial
- https://www.sec.gov/Archives/edgar/data/1430306/000199937125002523/tnxp-8k_031025.htm
- https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm
- https://ir.tonixpharma.com/news-events/press-releases/detail/1594/tonix-pharmaceuticals-presented-data-on-tnx-801-mpox
Not verified or not found
- Founding year: not read.
- Statement that most of the business is in other indications: not cited in these sources.
Questions
What does Tonix Pharmaceuticals do?
Tonix Pharmaceuticals was awarded up to $34 million by the US Department of Defense for a broad-spectrum antiviral programme, TNX-4200.
Where is Tonix Pharmaceuticals based?
HQ (as found): Berkeley Heights, NJ. HQ country: US.
Who owns Tonix Pharmaceuticals?
Publicly listed on Nasdaq (TNXP). Parent: none (publicly listed) (checked)
Profiles are compiled from public sources and sampled-checked, not fully audited. Last verified 17 October 2026. Report a correction